2593 related articles for article (PubMed ID: 75978)
1. Purification and immunologic evaluation of human melnoma-associated antigens.
McCabe RP; Ferrone S; Pellegrino MA; Kern DH; Holmes EC; Reisfeld RA
J Natl Cancer Inst; 1978 Apr; 60(4):773-7. PubMed ID: 75978
[TBL] [Abstract][Full Text] [Related]
2. Approaches for the isolation of biologically functional tumor-associated antigens.
Reisfeld RA; David GS; Ferrone S; Pellegrino MA; Holmes EC
Cancer Res; 1977 Aug; 37(8 Pt 2):2860-5. PubMed ID: 301432
[TBL] [Abstract][Full Text] [Related]
3. Detection of tumor-associated antigen in human melanoma cell line supernatants.
Grimm EA; Silver HK; Roth JA; Chee DO; Gupta RK; Morton DL
Int J Cancer; 1976 May; 17(5):559-64. PubMed ID: 1270174
[TBL] [Abstract][Full Text] [Related]
4. Targeting melanoma cells with human high molecular weight-melanoma associated antigen-specific antibodies elicited by a peptide mimotope: functional effects.
Luo W; Ko E; Hsu JC; Wang X; Ferrone S
J Immunol; 2006 May; 176(10):6046-54. PubMed ID: 16670313
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of two distinct antigens in spent tissue culture medium of a human malignant melanoma cell line.
Gupta RK; Irie RF; Chee DO; Kern DH; Morton DL
J Natl Cancer Inst; 1979 Aug; 63(2):347-56. PubMed ID: 88538
[No Abstract] [Full Text] [Related]
6. Production and characterization of xenogeneic antisera to tumor-associated antigen(s).
Gupta RK; Silver HK; Morton DL
J Surg Oncol; 1980; 13(1):75-89. PubMed ID: 6153230
[TBL] [Abstract][Full Text] [Related]
7. Studies of a melanoma tumor-associated antigen detected in the spent culture medium of a human melanoma cell line by allogeneic antibody. II. Immunobiologic characterization.
Gupta RK; Morton DL
J Natl Cancer Inst; 1984 Jan; 72(1):75-82. PubMed ID: 6582305
[TBL] [Abstract][Full Text] [Related]
8. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
Chee DO; Boddie AW; Roth JA; Holmes EC; Morton DL
Cancer Res; 1976 Apr; 36(4):1503-9. PubMed ID: 1260767
[TBL] [Abstract][Full Text] [Related]
9. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
[TBL] [Abstract][Full Text] [Related]
10. Isolation of a soluble tumor-associated antigen from human melanoma.
Roth JA; Holmes EC; Reisfeld RA; Slocum HK; Morton DL
Cancer; 1976 Jan; 37(1):104-10. PubMed ID: 1247946
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody defined-human melanoma-associated antigens: molecular and phylogenetic studies in normal serum.
Morgan AC; McIntyre RF
Mol Immunol; 1983 Dec; 20(12):1293-9. PubMed ID: 6656776
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
Natali PG; Bigotti A; Nicotra MR; Nardi RM; Delovu A; Segatto O; Ferrone S
Cancer Res; 1989 Mar; 49(5):1269-74. PubMed ID: 2917356
[TBL] [Abstract][Full Text] [Related]
13. Association of melanoma tumor antigen activity with beta2-microglobulin.
Malley A; Burger DR; Vandenbark AA; Frikke M; Finke P; Begley D; Acott K; Black J; Vetto RM
Cancer Res; 1979 Feb; 39(2 Pt 2):619-23. PubMed ID: 83915
[TBL] [Abstract][Full Text] [Related]
14. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
15. In vitro differentiation and antigenic changes in human melanoma cell lines.
Guarini L; Temponi M; Edwalds GM; Vita JR; Fisher PB; Ferrone S
Cancer Immunol Immunother; 1989; 30(5):262-8. PubMed ID: 2624919
[TBL] [Abstract][Full Text] [Related]
16. A radioimmunometric antibody-binding assay for evaluation of xenoantisera to melanoma-associated antigens.
McCabe RP; Quaranta V; Frugis L; Ferrone S; Reisfeld RA
J Natl Cancer Inst; 1979 Mar; 62(3):455-63. PubMed ID: 283276
[TBL] [Abstract][Full Text] [Related]
17. Antigens and antibodies in malignant melanoma.
Merimsky O; Shoenfeld Y; Chaitchik S; Yecheskel G; Fishman P
Tumour Biol; 1994; 15(4):188-202. PubMed ID: 7939169
[TBL] [Abstract][Full Text] [Related]
18. Lack of association of serologically detectable human melanoma-associated antigens with beta 2 microglobulin: serologic and immunochemical evidence.
McCabe RP; Indiveri F; Galloway DR; Ferrone S; Reisfeld RA
J Natl Cancer Inst; 1980 Oct; 65(4):703-7. PubMed ID: 6158590
[TBL] [Abstract][Full Text] [Related]
19. Two-step enrichment of HLA-DR antigens from spent medium of human malignant melanoma culture by flotation and density separation procedures.
Khosravi MJ; Liao SK
Immunol Commun; 1983; 12(4):387-96. PubMed ID: 6579021
[TBL] [Abstract][Full Text] [Related]
20. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
